Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Experience with intranasal zolmitriptan in cluster headache].

J Pascual1, A Navarro, A B Caminero

  • 1Servicio de Neurología, Hospital Universitario Marqués de Valdecilla, Santander. juliopascual@telefonica.net

Neurologia (Barcelona, Spain)
|April 1, 2006
PubMed
Summary

Intranasal zolmitriptan 5 mg offers a new, effective option for cluster headache relief, showing high patient preference and good tolerability compared to other triptans. This nasal formulation provides rapid symptom control for cluster headache sufferers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A phase II, multicenter, open-label, single-arm study of berzosertib plus topotecan in patients with relapsed platinum-resistant small-cell lung cancer (DDRiver SCLC 250).

ESMO open·2025
Same author

Malignant sinonasal paraganglioma: A major clinical and histopathological challenge in a rare entity.

Acta otorrinolaringologica espanola·2025
Same author

Efficacy of the ECHOMANTRA Individual Online Intervention to Support Recovery From Eating Disorders in Adolescent Patients: A Randomized Controlled Trial.

European eating disorders review : the journal of the Eating Disorders Association·2025
Same author

Mancha3D Code: Multipurpose Advanced Nonideal MHD Code for High-Resolution Simulations in Astrophysics.

Solar physics·2024
Same author

Last twenty-years activity of cardiovascular tissue banking in Barcelona.

Cell and tissue banking·2023
Same author

Changes of CD3+CD56+ γδ T cell number and apoptosis during hospital admission are related to mortality in septic patients.

Clinical immunology (Orlando, Fla.)·2022

Area of Science:

  • Neurology
  • Pharmacology
  • Clinical Medicine

Background:

  • Cluster headache is a debilitating neurological condition.
  • Current treatments include subcutaneous and oral triptans.
  • Intranasal zolmitriptan 5 mg is a novel formulation for acute symptom management.

Purpose of the Study:

  • To evaluate the clinical experience with intranasal zolmitriptan 5 mg in treating cluster headaches.
  • To compare patient preference and outcomes with previous triptan therapies.

Main Methods:

  • A cohort of 18 patients with cluster headache using intranasal zolmitriptan was analyzed.
  • Patient history included prior use of subcutaneous sumatriptan (17 patients) and oral triptans (8 patients).
  • Reasons for switching and patient preferences were recorded.

Related Experiment Videos

Main Results:

  • 12 out of 17 patients preferred intranasal zolmitriptan over subcutaneous sumatriptan due to convenience, tolerability, and efficacy.
  • 7 out of 8 patients preferred nasal zolmitriptan over oral triptans, citing superior subjective efficacy.
  • 11 patients experienced symptom relief within 30 minutes, with only 3 reporting mild adverse events.

Conclusions:

  • Intranasal zolmitriptan 5 mg presents a viable treatment option for cluster headache.
  • It is particularly beneficial for patients intolerant to subcutaneous sumatriptan or when oxygen therapy is inaccessible.
  • Further controlled trials are warranted to confirm the efficacy of nasal zolmitriptan for cluster headache.